A multi-institutional team of British researchers has determined that evidence suggests a high prevalence of comorbid medical conditions and related complaints among people with dementia, and that the presence of dementia may complicate clinical care for other conditions, and undermine a patient’s ability to manage a chronic condition. The…
News
Second Wind Dreams®, an Atlanta-based international non-profit organization for the gerontological population, is set to present its flagship program Virtual Dementia Tour (VDT®) next week, Thursday, November 6 in New York City. This year’s event is in commemoration of the organization’s National Take the Tour Day, which began in 2013 as a…
In a recent study published in the online version of Journal of Biological Chemistry scientists reported to have found a new target molecule that will help the fight against Alzheimer’s disease. The study is entitled, “The Spleen Tyrosine Kinase (syk) Regulates Alzheimer’s Aβ Production and Tau…
A group of investigators from the University of Melbourne, Australia recently developed a simple blood test that could very well change the future of diagnosing Alzheimer’s Disease, and may ultimately be a driving force behind the improvement of patient outcomes, as it allows earlier detection of this…
TauRx Hosts Event to Inform on bvFTD Trial at International Conference on Frontotemporal Dementias
TauRx Therapeutics Ltd, a spin-off company from the University of Aberdeen in Scotland, recently hosted a breakfast event to inform both patients and caregivers about their phase III clinical trial, which will test a treatment for behavioral variant Frontotemporal Dementia (bvFTD), and is currently enrolling participants. The “Meet the Experts” breakfast was held on …
The Alzheimer’s Association is awarding a new series of grants to support research on non-drug therapies for the treatment of Alzheimer’s disease as a way of advancing the search for a cure for the condition and meeting the needs of projects that are not funded either…
Caption: Amyloid plaques are found in the brains of people with Down syndrome and Alzheimer’s disease.Credit: Juan Gartner A study entitled “SortingNexin 27 Regulates Aβ Production through Modulatingγ-Secretase Activity” published in the online issue of Cell Reports reveals common molecular mechanisms between…
Design Of Micro And Nanoparticles To Improve Treatments For Alzheimer’s and Parkinson’s Diseases
At the Faculty of Pharmacy of the University of the Basque Country (Basque – Euskal Herriko Unibertsitatea; Spanish – Universidad del Pas Vasco – UPV/EHU) in Leioa, northern Spain, encapsulation techniques are being developed to deliver correctly and effectively certain drugs used to treat neurological diseases. Enara Herran, a researcher…
A recent study revealed the potential of a walnut-enriched diet to benefit brain-health. The animal study was published in the Journal of Alzheimer’s Disease and details how a diet including walnuts may have positive effects against Alzheimer’s disease by reducing the risk of contracting the disease, delaying…
Sleeping properly may help prevent neurodegenerative diseases like Alzheimer’s disease, as it is during sleep that the brain cleanses its system of the “waste” it produces, as explained by Jeff Iliff, who led a University of Rochester Medical Center research team at a recent TEDMED conference, in San Francisco. The researcher…
Recent Posts
- Researchers explore surgical treatment’s potential in Alzheimer’s March 2, 2026
- FDA fast-tracks expanded home injections for Alzheimer’s drug Leqembi February 2, 2026
- FDA decision on AXS-05 for Alzheimer’s agitation expected April 30 January 6, 2026
- Oral semaglutide fails to slow Alzheimer’s in pair of clinical trials December 2, 2025
- Canada gives conditional OK to early Alzheimer’s drug Leqembi November 4, 2025